Zimmer Biomet Holdings Inc.

122.97-0.3800-0.31%Vol 722.92K1Y Perf 0.49%
Dec 2nd, 2022 16:04 DELAYED
BID110.00 ASK133.50
Open122.06 Previous Close122.97
Pre-Market- After-Market122.97
 - -  - -%
Target Price
131.94 
Analyst Rating
Hold 2.91
Potential %
7.29 
Finscreener Ranking
     31.56
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
+     35.54
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★+     40.38
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
+     27.98
Price Range Ratio 52W %
65.15 
Earnings Rating
Sell
Market Cap25.81B 
Earnings Date
2nd Nov 2022
Alpha-0.01 Standard Deviation0.08
Beta1.17 

Today's Price Range

121.99123.52

52W Range

100.39135.05

5 Year PE Ratio Range

-166.3086.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
3.15%
1 Month
16.65%
3 Months
16.48%
6 Months
1.94%
1 Year
0.49%
3 Years
-14.25%
5 Years
7.33%
10 Years
94.35%

TickerPriceChg.Chg.%
ZBH122.97-0.3800-0.31
AAPL147.81-0.5000-0.34
GOOG100.83-0.4500-0.44
MSFT255.020.33000.13
XOM109.86-0.9400-0.85
WFC45.94-0.9300-1.98
JNJ178.880.14000.08
FB196.640.99000.51
GE86.881.62001.90
JPM135.16-1.0800-0.79
 
ProfitabilityValueIndustryS&P 500US Markets
69.40
6.10
19.60
0.60
3.29
RevenueValueIndustryS&P 500US Markets
7.15B
34.08
-1.10
-0.73
DividendsValueIndustryS&P 500US Markets
0.82
0.96
0.00
0.00
Payout ratio35.00
Earnings HistoryEstimateReportedSurprise %
Q03 20221.561.581.28
Q02 20221.631.8211.66
Q01 20221.401.6115.00
Q04 20211.961.95-0.51
Q03 20211.751.813.43
Q02 20211.841.903.26
Q01 20211.511.7113.24
Q04 20202.062.112.43
Earnings Per EndEstimateRevision %Trend
12/2022 QR1.831.10Positive
12/2022 FY6.840.59Positive
3/2023 QR1.56-4.88Negative
12/2023 FY6.94-2.12Negative
Next Report Date-
Estimated EPS Next Report1.56
Estimates Count12
EPS Growth Next 5 Years %7.70
Volume Overview
Volume722.92K
Shares Outstanding209.85K
Shares Float187.60M
Trades Count16.64K
Dollar Volume88.89M
Avg. Volume1.07M
Avg. Weekly Volume970.23K
Avg. Monthly Volume1.11M
Avg. Quarterly Volume1.12M

Zimmer Biomet Holdings Inc. (NYSE: ZBH) stock closed at 122.97 per share at the end of the most recent trading day (a -0.31% change compared to the prior day closing price) with a volume of 722.92K shares and market capitalization of 25.81B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 20000 people. Zimmer Biomet Holdings Inc. CEO is Bryan C. Hanson.

The one-year performance of Zimmer Biomet Holdings Inc. stock is 0.49%, while year-to-date (YTD) performance is -3.2%. ZBH stock has a five-year performance of 7.33%. Its 52-week range is between 100.39 and 135.05, which gives ZBH stock a 52-week price range ratio of 65.15%

Zimmer Biomet Holdings Inc. currently has a PE ratio of 89.10, a price-to-book (PB) ratio of 2.02, a price-to-sale (PS) ratio of 3.45, a price to cashflow ratio of 17.60, a PEG ratio of 2.32, a ROA of 1.23%, a ROC of 1.98% and a ROE of 2.23%. The company’s profit margin is 3.29%, its EBITDA margin is 19.60%, and its revenue ttm is $7.15 Billion , which makes it $34.08 revenue per share.

Of the last four earnings reports from Zimmer Biomet Holdings Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.56 for the next earnings report. Zimmer Biomet Holdings Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Zimmer Biomet Holdings Inc. is Hold (2.91), with a target price of $131.94, which is +7.29% compared to the current price. The earnings rating for Zimmer Biomet Holdings Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Zimmer Biomet Holdings Inc. has a dividend yield of 0.82% with a dividend per share of $0.96 and a payout ratio of 35.00%.

Zimmer Biomet Holdings Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.42, ATR14 : 2.74, CCI20 : 146.74, Chaikin Money Flow : 0.25, MACD : 3.15, Money Flow Index : 66.70, ROC : 6.82, RSI : 68.33, STOCH (14,3) : 93.26, STOCH RSI : 0.87, UO : 72.73, Williams %R : -6.74), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Zimmer Biomet Holdings Inc. in the last 12-months were: Chad F. Phipps (Option Excercise at a value of $2 186 970), Chad F. Phipps (Sold 35 149 shares of value $4 287 247 ), Lori Winkler (Option Excercise at a value of $0), Rachel Ellingson (Option Excercise at a value of $0), Sang Yi (Sold 2 800 shares of value $347 599 ), Suketu Upadhyay (Option Excercise at a value of $0), Zuilen Wilfred Van (Option Excercise at a value of $0), Zuilen Wilfred Van (Sold 531 shares of value $55 870 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (13.64 %)
3 (13.04 %)
3 (14.29 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
16 (72.73 %)
16 (69.57 %)
16 (76.19 %)
Moderate Sell
2 (9.09 %)
2 (8.70 %)
1 (4.76 %)
Strong Sell
1 (4.55 %)
2 (8.70 %)
1 (4.76 %)
Summary RatingHold
2.91
Hold
3.00
Hold
2.86

Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Close to 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.

CEO: Bryan C. Hanson

Telephone: +1 574 267-6131

Address: 345 East Main Street, Warsaw 46580, IN, US

Number of employees: 20 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

58%42%

Bearish Bullish

56%44%


News

Stocktwits